Strides Shasun receives USFDA approval for Cinacalcet Hydrochloride Tablets

Strides Shasun announced that its wholly owned subsidiary Strides Pharma Global Pte. Limited has received final approval for Cinacalcet Hydrochloride Tablets, 30 mg (base), 60 mg (base), and 90 mg (base) from the United States Food & Drug Administration (US FDA). Cinacalcet Hydrochloride Tablets is a generic version of Sensipar Tablets of Amgen Inc.

Powered by Capital Market - Live News